Multiple randomized trials have failed to demonstrate an incremental benefit of renal artery stenting (RAS) over medical therapy alone (MT) for atherosclerotic renal artery stenosis (ARAS). However, patients with ARAS… Click to show full abstract
Multiple randomized trials have failed to demonstrate an incremental benefit of renal artery stenting (RAS) over medical therapy alone (MT) for atherosclerotic renal artery stenosis (ARAS). However, patients with ARAS and acute coronary syndromes (ACS), decompensated heart failure (CHF), and/or
               
Click one of the above tabs to view related content.